DocStation, Inc.
Classification
Private
Financials
Revenue & Profit
Valuation
Ratios
People
Deals
M&A2024-03-15Completed
Investor Sponsors NorthBridge PE | Stake Tags 100% |
Deal Amount $120M | Is PE deal Yes |
Target Company Valuation $1.20 MM | Is deal PE backed Yes |
Techniques Acquisition of Assets, Taken Private | Total Acquired 100% |
Investor Sponsors
Deal Amount
$120M
Target Company Valuation
$1.20 MM
Techniques
Acquisition of Assets, Taken Private
Stake Tags
100%
Is PE deal
Yes
Is deal PE backed
Yes
Total Acquired
100%
Secondary Transaction2023-09-01Canceled
Investor Sponsors -- | Stake Tags Majority |
Deal Amount Undisclosed | Is PE deal No |
Target Company Valuation -- | Is deal PE backed Yes |
Techniques Secondary Sale, Management Buy-out (MBO) | Total Acquired 65% |
Investor Sponsors
--
Deal Amount
Undisclosed
Target Company Valuation
NaN
Techniques
Secondary Sale, Management Buy-out (MBO)
Stake Tags
Majority
Is PE deal
No
Is deal PE backed
Yes
Total Acquired
65%
Funding
About
About
DocStation, Inc. is a privately-held company that develops a cloud-based patient care platform for pharmacists. It offers DocStation that empowers pharmacists to create and maintain meaningful patient relationships, intervene intelligently, improve outcomes, and get paid; and provides health plans with functionalities and insights to clinical programs. It offers solutions for pharmacies, health plans, Medicare, Medicaid, and employers. It offers features, such as medical billing for pharmacy, revenue cycle management for pharmacy, patient appointment scheduling, hipaa compliant messaging and texting, clinical health assessments, pharmacy data analytics & patient health insights, value-based care, medication therapy management, security and compliance, and clinical programs. DocStation, Inc. was founded in 2017 by Joshua Matz and Sammuel Anderegg. DocStation, Inc. headquarters are located in Austin, Texas.
Keywords
Keywords
Classified
Private